AHA GUIDELINES Bundle (free trial)

Dyslipidemia 2026

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1543908

Contents of this Issue

Navigation

Page 82 of 105

83 Table 23. Physiological and Secondary Causes of Hypertriglyceridemia Categories Conditions and Medications Contributing to Hypertriglyceridemia Drugs* (Medications) Anesthesia: • Propofol Cardiology: • Beta-adrenergic–blocking agents • Thiazide and loop diuretic agents • Bile acid sequestrants (cholestyramine, colestipol, colesevelam) Endocrine: • Glucocorticosteroids • Anabolic steroids • Oral estrogens » Raloxifene » Clomiphene citrate » Estradiol » Ethinyl estradiol » Conjugated estrogens » Tamoxifen Dermatology: • Isotretinoin Infectious Disease: • HIV protease inhibitors Oncology: • Tamoxifen • L-asparaginase • Bexarotene • Cyclophosphamide Psychiatry: • Atypical antipsychotic agents (eg, olanzapine, mirtazapine, clozapine) Immunosuppressive agents: • Tacrolimus • Sirolimus • Cyclosporine • Interferons Disorders of metabolism • Overweight and obesity • Metabolic syndrome/insulin resistance • Weight gain after weight loss Physiological • Pregnancy (especially during the third trimester, when pregnancy- associated TG elevation is peaking ) * Caveats: TG-raising medications require careful monitoring ; minimizing other conditions that raise TG; and, when clinically appropriate, using alternatives. TG indicates triglycerides. Adapted from Virani et al. (cont'd)

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Dyslipidemia 2026